Published in J Immunol on February 01, 1975
Human platelet-initiated formation and uptake of the C5-9 complex of human complement. J Clin Invest (1976) 1.19
Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets. J Clin Invest (1977) 1.07
Mechanisms of lipopolysaccharide-initiated rabbit platelet responses: alternative complement pathway dependence of the lytic response. Infect Immun (1978) 1.01
Editorial: Complement activation and disease. Br Med J (1976) 0.75
C3 shunt activation in human serum chelated with EGTA. J Immunol (1972) 6.94
Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) (1980) 3.35
Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol (1993) 2.92
Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid. Infect Immun (1975) 2.04
Histoplasmosis in normal hosts. Medicine (Baltimore) (1981) 1.95
Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore) (1988) 1.91
Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin. J Immunol (1973) 1.89
Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg (1993) 1.87
Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg (1997) 1.83
Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg (1993) 1.73
State of the art: histoplasmosis. Am Rev Respir Dis (1978) 1.73
Immune responses to a soluble schistosomal egg antigen preparation during chronic primary infection with Schistosoma mansoni. J Immunol (1975) 1.72
Cellular differentiation in the thymus. 3. Surface properties of rat thymus and lymph node cells separated on density gradients. J Exp Med (1970) 1.60
The role of pyrazinamide in tuberculosis chemotherapy. Chest (1988) 1.48
Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore) (1972) 1.44
Immunologic aspects of host responses to schistosomiasis: resistance, immunopathology, and eosinophil involvement. Prog Allergy (1978) 1.39
Pathogenesis and clinical spectrum of histoplasmosis. South Med J (1973) 1.39
Adoptive suppression of granuloma formation. J Exp Med (1976) 1.38
Schistosomiasis vaccine:research to development. Parasitol Today (1998) 1.38
Gram-negative bacillary endocarditis. Interpretation of the serum bactericial test. Am J Med (1975) 1.34
Schistosomal egg antigen-induced lymphocyte blastogenesis in experimental murine Schistosoma mansoni infection. J Immunol (1971) 1.33
Blockade of the flush associated with metastatic gastric carcinoid by combined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature. N Engl J Med (1979) 1.32
Schistosoma mansoni: simplified method for the production of schistosomules. Exp Parasitol (1974) 1.30
Immune responses during human schistosomiasis mansoni. V. Suppression of schistosome antigen-specific lymphocyte blastogenesis by adherent/phagocytic cells. J Immunol (1979) 1.30
Immune responses during human schistosomiasis mansoni. III. Regulatory effect of patient sera on human lymphocyte blastogenic responses to schistosome antigen preparations. Am J Trop Med Hyg (1977) 1.29
Staphylococci-induced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor. J Clin Invest (1979) 1.29
Immune responses during human schistosomiasis mansoni. I. In vitro lymphocyte blastogenic responses to heterogeneous antigenic preparations from schistosome eggs, worms and cercariae. Int Arch Allergy Appl Immunol (1977) 1.28
Modulation of Schistosoma mansoni egg-induced granuloma formation: I-J restriction of T cell-mediated suppression in a chronic parasitic infection. Proc Natl Acad Sci U S A (1981) 1.27
Prevalence of trachoma in school children and ophthalmological outpatients in rural Egypt. Am J Trop Med Hyg (1987) 1.27
The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. AIDS (2000) 1.26
Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection. J Infect Dis (2001) 1.24
In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni. Reduction of irradiated cercariae-induced resistance. J Immunol (1988) 1.23
Adoptive suppression of granuloma formation by T lymphocytes and by lymphoid cells sensitive to cyclophosphamide. Cell Immunol (1979) 1.23
Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. Am J Trop Med Hyg (1998) 1.20
Eosinophils and immune mechanisms: production of the lymphokine eosinophil stimulation promoter (ESP) in vitro by isolated intact granulomas. J Reticuloendothel Soc (1975) 1.19
Schistosoma mansoni: eosinophilia and the development of lymphocyte blastogenesis in response to soluble egg antigen in inbred mice. Exp Parasitol (1972) 1.17
Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int Immunol (1994) 1.16
Immune responses during human schistosomiasis mansoni. IV. Induction of suppressor cell activity by schistosome antigen preparations and concanavalin A. J Immunol (1978) 1.15
Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. I. Eosinophilia and immunologic responses to a schistosomal egg preparation. Am J Pathol (1973) 1.14
Tuberculous meningitis. Infect Dis Clin North Am (1990) 1.14
The effects of bacterial endotoxin on rabbit platelets. V. Heat labile plasma factor requirements of endotoxin-induced platelet injury. J Immunol (1967) 1.14
Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol (1996) 1.14
Intradermal immune responses to a schistosomal egg antigen during experimental murine Schistosoma mansoni infection. Proc Soc Exp Biol Med (1972) 1.14
Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. II. Pathology and altered pathogenesis. Am J Pathol (1973) 1.13
Interaction of Histoplasma capsulatum with human platelets. J Infect Dis (1980) 1.13
Effects of bacterial endotoxin on rabbit platelets. IV. The divalent ion requirements of endotoxin-induced and immunologically induced platelet injury. J Exp Med (1966) 1.13
Mixed lymphocyte blastogenesis in response to multiple histocompatibility antigens. J Immunol (1969) 1.12
Tuberculosis and acquired immunodeficiency syndrome: a historical perspective on recent developments. Am J Med (1994) 1.11
Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment. Am J Trop Med Hyg (2000) 1.11
Plasma histamine changes during provoked bronchospasm in asthmatic patients. J Allergy Clin Immunol (1976) 1.09
Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin. Am Rev Respir Dis (1990) 1.08
T lymphocytes that contribute to the immunoregulation of granuloma formation in chronic murine schistosomiasis. J Immunol (1981) 1.08
Cytokine regulation of human immune response to Schistosoma mansoni: analysis of the role of IL-4, IL-5 and IL-10 on peripheral blood mononuclear cell responses. Scand J Immunol (1997) 1.06
Studies on human leukocyte motility. II. Effects of bacterial endotoxin on leukocyte migration, adhesiveness, and aggregation. Yale J Biol Med (1967) 1.05
Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans R Soc Trop Med Hyg (1995) 1.04
Cytotoxic effect of normal rabbit serum on rat lymphoid cells. Transplantation (1970) 1.04
Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas' disease. Am J Trop Med Hyg (1993) 1.03
Current perspectives in small cell lung cancer. Chest (1984) 1.03
Immune responses during human Schistosomiasis mansoni. VIII. Differential in vitro cellular responsiveness to adult worm and schistosomular tegumental preparations. Am J Trop Med Hyg (1983) 1.02
Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease. Am J Trop Med Hyg (1986) 1.02
Eosinophil-mediated destruction of Schistosoma mansoni eggs III. lymphokine involvement in the induction of eosinophil functional abilities. Cell Immunol (1978) 1.01
Immune responses during human schistosomiasis mansoni. VI. In vitro nonspecific suppression of phytohemagglutinin responsiveness induced by exposure to certain schistosomal preparations. J Immunol (1979) 1.00
Partial purification and characterization of Schistosoma mansoni soluble egg antigen with Con A-Sepharose chromatography. J Immunol (1979) 1.00
Comparison of the effects of divalent ion chelating agents on complement-mediated hemolysis in rabbit and human serum. J Immunol (1969) 0.99
Immunoaffinity purification of Schistosoma mansoni soluble egg antigens. J Immunol (1979) 0.98
Effect of metabolic acidosis and alkalosis on human platelet aggregation induced by epinephrine and ADP. Proc Soc Exp Biol Med (1974) 0.98
Immune responses during human schistosomiasis mansoni. XVIII. Immunologic status of pregnant women and their neonates. Scand J Immunol (1992) 0.98
Comparison of antibody isotype responses to Schistosoma mansoni antigens by infected and putative resistant individuals living in an endemic area. Parasite Immunol (1995) 0.98
Human antibody responses against schistosomal antigens. I. Antibodies from patients with Ancylostoma, Ascaris lumbricoides or Schistosoma mansoni infections react with schistosome antigens. Am J Trop Med Hyg (1988) 0.98
Apical localization of pulmonary tuberculosis, chronic pulmonary histoplasmosis, and progressive massive fibrosis of the lung. Chest (1983) 0.98
Idiotypic sensitization in utero of children born to mothers with schistosomiasis or Chagas' disease. J Clin Invest (1989) 0.97
Self and nonself stimulatory molecules induce preferential expansion of CD5+ B cells or activated T cells of chagasic patients, respectively. Scand J Immunol (2000) 0.97
Schistosoma mansoni: relationship of tumor necrosis factor-alpha to morbidity and collagen deposition in chronic experimental infection. Exp Parasitol (1996) 0.96
Eosinophil-mediated destruction of Schistosoma mansoni eggs. J Reticuloendothel Soc (1976) 0.96
Spleen cells from Schistosoma mansoni-infected mice produce diffusible stimulator of eosinophilopoiesis in vivo. Nature (1976) 0.95
Cellular differentiation in the thymus. II. Thymus-specific antigens in rat thymus and peripheral lymphoid cells. J Immunol (1970) 0.94
Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. III. Immunity and longitudinal studies of in vitro responsiveness after treatment. Trans R Soc Trop Med Hyg (1986) 0.94
CNS tuberculosis. Neurol Clin (1986) 0.94
Chemotherapy and radiation therapy for non-small cell lung carcinoma. Clin Chest Med (1982) 0.93
Eosinophils and immune mechanisms. IV. Culture conditions, antigen requirements, production kinetics and immunologic specificity of the lymphokine eosinophil stimulation promoter. Cell Immunol (1976) 0.93
Neonatal exposure to idiotype induces Schistosoma mansoni egg antigen-specific cellular and humoral immune responses. J Immunol (1999) 0.92
Schistosoma mansoni: susceptibility differences between male and female mice can be mediated by testosterone during early infection. Exp Parasitol (1997) 0.92
Eosinophils and immune mechanisms. II. Partial characterization of the lymphokine eosinophil stimulation promoter. J Immunol (1974) 0.92
Schistosoma japonicum soluble egg antigens: separation by can A chromatography and immunoaffinity purification. Mol Immunol (1981) 0.92
Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni infections. Am J Pathol (1993) 0.92
Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy. Parasite Immunol (1996) 0.91
Tranformation of lymphocytes of normal and hospitalized adults by Candida albicans extract. Proc Soc Exp Biol Med (1973) 0.91
Chronic pulmonary histoplasmosis. Medicine (Baltimore) (1976) 0.91
The effect of pH on human platelet aggregation induced by epinephrine and ADP. Proc Soc Exp Biol Med (1972) 0.90
Eosinophils and immune mechanisms. III. Production of the lymphokine eosinophil stimulation promoter by mouse T lymphocytes. J Immunol (1976) 0.90
Neonatal idiotypic exposure alters subsequent cytokine, pathology, and survival patterns in experimental Schistosoma mansoni infections. J Exp Med (1999) 0.90
Immune responses during human schistosomiasis mansoni. XVI. Idiotypic differences in antibody preparations from patients with different clinical forms of infection. J Immunol (1989) 0.90